MIR3670-1

Across TCGA pan-cancer cohorts, MIR3670-1 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR3670-1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR3670-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3670-1 expression acts as an unfavorable survival marker.

STAD, READ, and ESCA are the cancer types where MIR3670-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.126	0.688	<.001	108	view →
READ	OS	Tertile	All	0.183	0.828	<.001	36	view →
ESCA	OS	Tertile	II,III,IV	0.249	0.545	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR3670-1–STAD (OS)

Open the STAD breakdown →